Treatment of LUTS Secondary to BPH While Preserving Sexual Function: Randomized Controlled Study of Prostatic Urethral Lift

Journal of Sexual Medicine

Volumn 11, Issue 1, 2014, Pages 279-287

  Mcvary, Kevin T ^a   Gange, Steven N ^b   Shore, Neal D ^c   Bolton, Damien M ^d   Cowan, Barrett E ^e   Brown, B Thomas ^f   Te, Alexis E ^g   Chin, Peter T ^h   Rukstalis, Daniel B ⁱ   Roehrborn, Claus G ^j  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b Western Urological Clinic   (United States)

^c Carolina Urologic Research Center   (United States)

^d AUSTIN HOSPITAL   (Australia)

^e Urology Associates   (United States)

^f Atlantic Urological Associates   (United States)

^g WEILL CORNELL MEDICAL CENTER   (United States)

^h Figtree Private Hospital   (Australia)

ⁱ WAKE FOREST UNIVERSITY   (United States)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

Benign Prostatic Hyperplasia; Ejaculatory Dysfunction; Erectile Dysfunction; Implant; Retrograde Ejaculation; Sexual Function

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTOSCOPY; ERECTILE DYSFUNCTION; HUMAN; HUMAN TISSUE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE VOLUME; PROSTATIC URETHRAL LIFT; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL HEALTH; URINE FLOW RATE; UROLOGICAL IMPLANT;

BENIGN PROSTATIC HYPERPLASIA; EJACULATORY DYSFUNCTION; ERECTILE DYSFUNCTION; IMPLANT; RETROGRADE EJACULATION; SEXUAL FUNCTION;

AGED; CYSTOSCOPY; EJACULATION; ERECTILE DYSFUNCTION; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; ORGAN SIZE; PENILE ERECTION; PROSTATE; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; TREATMENT OUTCOME; URETHRA; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 84892672410     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12333     Document Type: Article

References (32)

1. Roehrborn CG. Current medical therapies for men with lower urinary symptoms and benign prostatic hypertrophy. Achievements and limitations. Rev Urol 2008;10:14-25.
2. Verhamme KM, Dieleman JP, Bieunink GS, Bosch JL, Stricker BH, Sturkenboom MC. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: The Triumph Project. Eur Urol 2003;58:539-545.
3. Lowe FC. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Sexual function. BJU Int 2005;95:12-18.
4. Hellstrom WJ, Giuliano F, Rosen RC. Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment. Urology 2009;74:15-21.
5. Arai Y, Aoki Y, Okubo K, Maeda H, Terada N, Matsuta Y, Mackawa S, Ogura K. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: A prospective study. J Urol 2000;164:1206-1211.
6. Bell J, Laborde E. Update on sexual impact of treatment for Benign Prostatic Hyperplasia. Curr Urol Rep 12 October 2012;13:433-440.
7. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE Jr., Gonzalez CM, Kaplan SA, Penson DR, Ulchaker JC, Wei JT. American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2010.
8. Roehrborn CG, McConnell JD, Bary MJ, Benaim EA, Blute ML, Bruskewitz R, Holtgrewe HL, Kaplan SA, Lange JL, Lowe FC, Roberts RG, Stein B. American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2003.
9. McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2007;177:1401-1407.
10. Porst H, Roehrborn CG, Secrest RJ, Esler A, Viktrup L. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: Analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies. J Sex Med 2013;10:2044-2052. Jun 19. doi: 10.1111/jsm.12212.
11. Gravas S, Bachmann A, Reich O, Roehrborn CG, Gilling PJ, De La Rosette J. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int 2011;107:1030-1043.
12. Spailviero M, Strom KH, Gu X, Araki M, Culkin DJ, Wong C. Does greenlight HPS laser photoselective vaporization prostatectomy affect sexual function? J Endourol 2010;24:2051-2057.
13. Frieben RW, Lin HC, Hinh PP, Berardinelli F, Canfield SE, Wang R. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function; a systematic review. Asian J Androl 2010;12:500-508.
14. Gupta N, Sivaramakrisna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holimium laser enucleation of the prostate for managing benign prostatic hyperplasia >40g. BJU Int 2006;97:85-89.
15. Montorsi F, Moncada I. Safety and tolerability of treatment for BPH. Eur Urol Suppl 2006;5:989-1024.
16. McNicholas TA, Woo HH, Chin PT, Bolton D, Fernandez Arjona M, Sievert KD, Schoenthaler M, Wetterauer U, Vrijhof EJ, Gange SN, Montorsi F. Minimally invasive Prostatic Urethral Lift: Surgical technique and multinational study. Eur Urol 2013;64:292-299. http://dx.doi.org/10.1016/j.eururo.2013.01.008.
17. Woo HH, Chin PT, McNicholas TA, Harscharan G, Plante MK, Bruskewitz RC, Roehrborn CG. Safety and feasibility of the prostatic urethral lift: A novel minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hypertrophy (BPH). BJU Int 2011;108:82-88.
18. Chin PT, Bolton DM, Rashid JG, Thavaseelan J, Yu RJ, Roehrborn CG, Woo HH. Prostatic Urethral Lift: Two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia. Urology 2012;79:5-11.
19. Woo HH, Bolton DM, Laborde E, Jack G, Chin PT, Rashid P, Thavaseelan J, McVary KT. Preservation of sexual function with the prostatic urethral lift: A novel treatment for lower urinary tract symptoms secondary to benign prostatic hypertrophy. J Sex Med 2012;9:568-575.
20. Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB. Multi-Center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: The L.I.F.T. study. J Urol 2013. Jun 10. pii: S0022-5347(13)04597-7. doi: 10.1016/j.juro.2013.05.116 [Epub ahead of print].
21. Roehrborn C, Peminger G, Newhall P, Denstedt J, Razvi H, Chin J, Perlmutter A, Barzell W, Whitmore W, Fritzsch R, Sanders J, Sech S, Womack S. Microwave thermotherapy for benign prostatic hyperplasia with the dornier urowave: Results of a randomized, double-blind, multicenter, sham-controlled trial. Urology 1998;51:19.
22. Haltbakk J, Hanestad BRT, Hunskaar S. Relevance and variability of the severity of incontinence and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms. BJU Int 2005;96:83.
23. Haltbakk J, Hanestad BR, Hunskaar S. How important are men's lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL). Qual Life Res 2005;14:1733.
24. Helgason AR, Adolfsson J, Dickman P, Fredrikson M, Arver S, Steineck G. Waning sexual function-the most important disease-specific distress for patients with prostate cancer. Br J Cancer 1996;73:1417.
25. Laumann EO, Paik A, Glasser DB, Kang JH, Wang T, Levinson B, Moreira ED Jr, Nicolosi A, Gingell C. A cross-national study of subjective sexual well-being among older women and men: Findings from the Global Study of Sexual Attitudes and Behaviors. Arch Sex Behav 2006;35:145.
26. McVary K. Lower urinary tract symptoms and sexual dysfunction: Epidemiology and pathophysiology. BJU Int 2006;97(suppl 2):23-28; discussion 44-5.
27. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O'Leary MP, Puppo P, Chris R, Giuliano F. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637-649.
28. Mamoulakis C, Skolarikos A, Schulze M, Scoffone CM, Rassweiler JJ, Alivisatos G, Scarpa RM, de la Rosette JMCH. Bipolar vs monopolar transurethral resection of the prostate: Evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int 2013;112:109-120.
29. Akman T, Binbay M, Tekinarslan E, Tepeler A, Akcay M, Ozgor F, Ugurlu M, Mulsumanoglu A. Effects of bipolar and monopolar transurethral resection of the prostate on urinary and erectile function: A prospective randomized comparative study. BJU Int 2012;111:129-136.
30. Elshal AM, Elmansy HM, Elcoushy MA, Elhilali MM. Male sexual function outcome after three laser prostate surgical techniques: A single center perspective. Urology 2012;80:1098-1104.
31. Bruyère F, Puichaud A, Pereira H, Faivre d'Arcier B, Rouanet A, Floc'h AP, Bodin T, Brichart N. Influence of photoselective vaporization of the prostate on sexual function: Results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 2010;58:207-211.
32. Kumar A, Vasudeva P, Kumar N, Nanda B, Mohanty NK. Evaluation of effect of photoselective vaporization of the prostate on sexual function in a prospective study: A single center experience in 150 patients. J Endourol 2012;26:1-5.